Condition
Reflux Disease, Gastro-Esophageal
Total Trials
5
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (4)
Trial Status
Completed2
Recruiting1
Unknown1
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07148492Not ApplicableRecruitingPrimary
Antireflux Suture In One Anastomsis Gastric Bypass
NCT06812650Not ApplicableCompletedPrimary
Breathing Exercises in Patients With Gastroesophageal Reflux
NCT07041060Not ApplicableCompleted
Evaluation of the Efficacy and Safety of Eolo in Patients With NERD
NCT05579587Withdrawn
Transoral Incisionless Fundoplication (TIF) for Laryngopharyngeal Reflux (LPR) Patients
NCT06170060Not ApplicableUnknownPrimary
Treatment of Reflux With Sleeve Gastrectomy
Showing all 5 trials